

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine metabolic process (GO:0046087) | 8.54397755 |
| 2 | cytidine catabolic process (GO:0006216) | 8.54397755 |
| 3 | cytidine deamination (GO:0009972) | 8.54397755 |
| 4 | negative T cell selection (GO:0043383) | 8.09845057 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.79402111 |
| 6 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 7.77447386 |
| 7 | negative thymic T cell selection (GO:0045060) | 7.64985828 |
| 8 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 7.34476304 |
| 9 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 7.05191588 |
| 10 | DNA deamination (GO:0045006) | 6.99547617 |
| 11 | interferon-gamma production (GO:0032609) | 6.39796943 |
| 12 | leukocyte aggregation (GO:0070486) | 6.39609153 |
| 13 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.32786483 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.23390959 |
| 15 | negative regulation of cell killing (GO:0031342) | 6.23390959 |
| 16 | cellular response to interleukin-15 (GO:0071350) | 6.01583211 |
| 17 | regulation of gamma-delta T cell activation (GO:0046643) | 5.86544141 |
| 18 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.85680465 |
| 19 | * thymic T cell selection (GO:0045061) | 5.71069190 |
| 20 | * T cell receptor signaling pathway (GO:0050852) | 5.68994724 |
| 21 | response to interleukin-15 (GO:0070672) | 5.58829309 |
| 22 | * T cell selection (GO:0045058) | 5.43454482 |
| 23 | T cell migration (GO:0072678) | 5.42902268 |
| 24 | * positive T cell selection (GO:0043368) | 5.41727347 |
| 25 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.41229419 |
| 26 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.40788182 |
| 27 | regulation of T cell tolerance induction (GO:0002664) | 5.27541698 |
| 28 | * T cell costimulation (GO:0031295) | 5.16070932 |
| 29 | * positive thymic T cell selection (GO:0045059) | 5.10499876 |
| 30 | * lymphocyte costimulation (GO:0031294) | 5.10216138 |
| 31 | regulation of T cell receptor signaling pathway (GO:0050856) | 5.09951854 |
| 32 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.00239936 |
| 33 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.00239936 |
| 34 | sequestering of actin monomers (GO:0042989) | 4.93841975 |
| 35 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.93563820 |
| 36 | * antigen receptor-mediated signaling pathway (GO:0050851) | 4.81719758 |
| 37 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.73767776 |
| 38 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.65070629 |
| 39 | negative regulation of T cell apoptotic process (GO:0070233) | 4.59971361 |
| 40 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.59328021 |
| 41 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.59328021 |
| 42 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.56717093 |
| 43 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.47437592 |
| 44 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.35811811 |
| 45 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.35811811 |
| 46 | polyketide metabolic process (GO:0030638) | 4.30562711 |
| 47 | doxorubicin metabolic process (GO:0044598) | 4.30562711 |
| 48 | daunorubicin metabolic process (GO:0044597) | 4.30562711 |
| 49 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.29995478 |
| 50 | positive regulation of tolerance induction (GO:0002645) | 4.26456245 |
| 51 | mast cell activation (GO:0045576) | 4.25714546 |
| 52 | regulation of chronic inflammatory response (GO:0002676) | 4.25018622 |
| 53 | negative regulation by host of viral transcription (GO:0043922) | 4.23012145 |
| 54 | negative regulation of T cell mediated immunity (GO:0002710) | 4.22092175 |
| 55 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.21829141 |
| 56 | regulation of lymphocyte chemotaxis (GO:1901623) | 4.18867948 |
| 57 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.14972014 |
| 58 | positive regulation of interleukin-8 secretion (GO:2000484) | 4.12891221 |
| 59 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.11624893 |
| 60 | positive regulation of B cell differentiation (GO:0045579) | 4.08896712 |
| 61 | regulation of B cell differentiation (GO:0045577) | 4.08063746 |
| 62 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.05762288 |
| 63 | negative regulation of viral genome replication (GO:0045071) | 4.04123700 |
| 64 | activated T cell proliferation (GO:0050798) | 4.02843199 |
| 65 | positive regulation of cell killing (GO:0031343) | 3.90373140 |
| 66 | actin nucleation (GO:0045010) | 3.88926994 |
| 67 | regulation of activation of Janus kinase activity (GO:0010533) | 3.87986636 |
| 68 | regulation of cell killing (GO:0031341) | 3.85536207 |
| 69 | positive regulation of lymphocyte migration (GO:2000403) | 3.83641313 |
| 70 | positive regulation of T cell chemotaxis (GO:0010820) | 3.83459668 |
| 71 | regulation of T cell chemotaxis (GO:0010819) | 3.83459668 |
| 72 | positive regulation of B cell mediated immunity (GO:0002714) | 3.83021222 |
| 73 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.83021222 |
| 74 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.78114634 |
| 75 | regulation of tolerance induction (GO:0002643) | 3.75444794 |
| 76 | cytolysis (GO:0019835) | 3.69061070 |
| 77 | natural killer cell activation (GO:0030101) | 3.68861894 |
| 78 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.68249644 |
| 79 | positive regulation of isotype switching (GO:0045830) | 3.67497208 |
| 80 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.66507879 |
| 81 | positive regulation of granulocyte differentiation (GO:0030854) | 3.65562513 |
| 82 | lymphocyte chemotaxis (GO:0048247) | 3.65358635 |
| 83 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.64478921 |
| 84 | positive regulation of interleukin-2 production (GO:0032743) | 3.63136521 |
| 85 | * T cell differentiation (GO:0030217) | 3.62458174 |
| 86 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.59667827 |
| 87 | eosinophil chemotaxis (GO:0048245) | 3.59617132 |
| 88 | response to type I interferon (GO:0034340) | 3.59501214 |
| 89 | tolerance induction (GO:0002507) | 3.59285560 |
| 90 | regulation of B cell mediated immunity (GO:0002712) | 3.56136548 |
| 91 | cellular response to type I interferon (GO:0071357) | 3.55551941 |
| 92 | type I interferon signaling pathway (GO:0060337) | 3.55551941 |
| 93 | * T cell activation (GO:0042110) | 3.54599367 |
| 94 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.53350898 |
| 95 | regulation of isotype switching (GO:0045191) | 3.52803644 |
| 96 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.50922588 |
| 97 | positive regulation of defense response to virus by host (GO:0002230) | 3.49641410 |
| 98 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.49389357 |
| 99 | heterotypic cell-cell adhesion (GO:0034113) | 3.48793887 |
| 100 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.48637830 |
| 101 | regulation of response to interferon-gamma (GO:0060330) | 3.48089086 |
| 102 | leukocyte cell-cell adhesion (GO:0007159) | 3.44169641 |
| 103 | alpha-beta T cell differentiation (GO:0046632) | 3.44014659 |
| 104 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.41619479 |
| 105 | positive regulation of humoral immune response (GO:0002922) | 3.40933145 |
| 106 | regulation of regulatory T cell differentiation (GO:0045589) | 3.40786747 |
| 107 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.37345944 |
| 108 | T cell homeostasis (GO:0043029) | 3.36608024 |
| 109 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.36280775 |
| 110 | macrophage chemotaxis (GO:0048246) | 3.35239543 |
| 111 | positive regulation of interferon-gamma production (GO:0032729) | 3.31702901 |
| 112 | alpha-beta T cell activation (GO:0046631) | 3.31243014 |
| 113 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.30451600 |
| 114 | positive regulation of DNA recombination (GO:0045911) | 3.28893304 |
| 115 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.26093364 |
| 116 | * immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.24836932 |
| 117 | eosinophil migration (GO:0072677) | 3.24634346 |
| 118 | regulation of T cell apoptotic process (GO:0070232) | 3.23654494 |
| 119 | regulation of calcium-mediated signaling (GO:0050848) | 3.23515238 |
| 120 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.20067236 |
| 121 | lymphocyte migration (GO:0072676) | 3.19339889 |
| 122 | dendritic cell chemotaxis (GO:0002407) | 3.19172985 |
| 123 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.18417585 |
| 124 | Peyers patch development (GO:0048541) | 3.18417585 |
| 125 | regulation of lymphocyte migration (GO:2000401) | 3.17812680 |
| 126 | T-helper cell differentiation (GO:0042093) | 3.16762086 |
| 127 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.16762086 |
| 128 | positive regulation of T cell migration (GO:2000406) | 3.15822233 |
| 129 | cellular defense response (GO:0006968) | 3.15084638 |
| 130 | positive regulation of interleukin-4 production (GO:0032753) | 3.14541338 |
| 131 | regulation of viral genome replication (GO:0045069) | 3.11351168 |
| 132 | regulation of defense response to virus by virus (GO:0050690) | 3.09073863 |
| 133 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.08750164 |
| 134 | regulation of response to tumor cell (GO:0002834) | 3.08542698 |
| 135 | positive regulation of response to tumor cell (GO:0002836) | 3.08542698 |
| 136 | positive regulation of immune response to tumor cell (GO:0002839) | 3.08542698 |
| 137 | regulation of immune response to tumor cell (GO:0002837) | 3.08542698 |
| 138 | positive regulation of T cell mediated immunity (GO:0002711) | 3.07172019 |
| 139 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.02224421 |
| 140 | negative regulation of B cell proliferation (GO:0030889) | 2.99231399 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.60385008 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.77797534 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.90074042 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.72815879 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.53447399 |
| 6 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.05061664 |
| 7 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.93956520 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.87388418 |
| 9 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.65888930 |
| 10 | MYB_26560356_Chip-Seq_TH2_Human | 3.43188426 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.33528020 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.08887066 |
| 13 | MAF_26560356_Chip-Seq_TH1_Human | 2.93428895 |
| 14 | MYC_22102868_ChIP-Seq_BL_Human | 2.80725554 |
| 15 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.77873589 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.76320370 |
| 17 | * MYB_26560356_Chip-Seq_TH1_Human | 2.74842382 |
| 18 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.71708183 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.63376257 |
| 20 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.62874811 |
| 21 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.60735844 |
| 22 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.59406641 |
| 23 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.51243814 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.47463307 |
| 25 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.24898048 |
| 26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09967740 |
| 27 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.01447179 |
| 28 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 2.00305520 |
| 29 | * MAF_26560356_Chip-Seq_TH2_Human | 1.96345739 |
| 30 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.94533088 |
| 31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.91699697 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.86625960 |
| 33 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82197123 |
| 34 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.81331961 |
| 35 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.78389064 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.73489465 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.61051051 |
| 38 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.60734515 |
| 39 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.59291009 |
| 40 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57991047 |
| 41 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.53683991 |
| 42 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.45386795 |
| 43 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.43686857 |
| 44 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.43416320 |
| 45 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.41260994 |
| 46 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.38287359 |
| 47 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36553666 |
| 48 | GATA3_26560356_Chip-Seq_TH2_Human | 1.30578567 |
| 49 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29199347 |
| 50 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25660482 |
| 51 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24823512 |
| 52 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.24304465 |
| 53 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.24185149 |
| 54 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.22393688 |
| 55 | SPI1_23127762_ChIP-Seq_K562_Human | 1.22326576 |
| 56 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.22170798 |
| 57 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.20196395 |
| 58 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.17860222 |
| 59 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.17253567 |
| 60 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.15506857 |
| 61 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.14453012 |
| 62 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11098309 |
| 63 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.10092055 |
| 64 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09396520 |
| 65 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.05947441 |
| 66 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.04341680 |
| 67 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.03535720 |
| 68 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.00271323 |
| 69 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.99900790 |
| 70 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97991922 |
| 71 | GATA3_26560356_Chip-Seq_TH1_Human | 0.97469276 |
| 72 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.97398357 |
| 73 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.96750327 |
| 74 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.96211303 |
| 75 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.94977734 |
| 76 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.94784447 |
| 77 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.93685139 |
| 78 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92057903 |
| 79 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.89883786 |
| 80 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.89731294 |
| 81 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89427477 |
| 82 | * NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.87109430 |
| 83 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.86745410 |
| 84 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.85689334 |
| 85 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84257968 |
| 86 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.83275724 |
| 87 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.82982762 |
| 88 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.82343114 |
| 89 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.81571244 |
| 90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.81181980 |
| 91 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.80486778 |
| 92 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.80407878 |
| 93 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.79198415 |
| 94 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.79073292 |
| 95 | P300_27268052_Chip-Seq_Bcells_Human | 0.78966845 |
| 96 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78816972 |
| 97 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.78574229 |
| 98 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.78224042 |
| 99 | VDR_22108803_ChIP-Seq_LS180_Human | 0.77441373 |
| 100 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76043554 |
| 101 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.75666090 |
| 102 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.75204392 |
| 103 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.74390224 |
| 104 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.73588363 |
| 105 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.73575415 |
| 106 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.72049255 |
| 107 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.71779558 |
| 108 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.70044266 |
| 109 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.70033839 |
| 110 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.69960818 |
| 111 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.69914571 |
| 112 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.69571107 |
| 113 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.68972785 |
| 114 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.66360914 |
| 115 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.65381992 |
| 116 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.65128092 |
| 117 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.64068041 |
| 118 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.63271622 |
| 119 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.62550574 |
| 120 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.62346918 |
| 121 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.62327020 |
| 122 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.62103019 |
| 123 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.61254426 |
| 124 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.59384143 |
| 125 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.59322929 |
| 126 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.58912241 |
| 127 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.57872296 |
| 128 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.57840302 |
| 129 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.57750508 |
| 130 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.56397969 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 6.05939614 |
| 2 | MP0005671_abnormal_response_to | 5.34532089 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.55767629 |
| 4 | MP0000685_abnormal_immune_system | 3.48256191 |
| 5 | MP0002166_altered_tumor_susceptibility | 3.39111009 |
| 6 | MP0009785_altered_susceptibility_to | 3.31450537 |
| 7 | MP0001800_abnormal_humoral_immune | 3.08206530 |
| 8 | MP0002006_tumorigenesis | 2.99449499 |
| 9 | MP0005387_immune_system_phenotype | 2.95719545 |
| 10 | MP0001790_abnormal_immune_system | 2.95719545 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.95110995 |
| 12 | MP0002420_abnormal_adaptive_immunity | 2.90963888 |
| 13 | MP0001819_abnormal_immune_cell | 2.89472511 |
| 14 | MP0002723_abnormal_immune_serum | 2.84962561 |
| 15 | MP0009333_abnormal_splenocyte_physiolog | 2.80785887 |
| 16 | * MP0002398_abnormal_bone_marrow | 2.77711398 |
| 17 | MP0003724_increased_susceptibility_to | 2.76885008 |
| 18 | MP0006082_CNS_inflammation | 2.72896158 |
| 19 | MP0005025_abnormal_response_to | 2.67840142 |
| 20 | * MP0000703_abnormal_thymus_morphology | 2.66472855 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.50319161 |
| 22 | MP0004381_abnormal_hair_follicle | 2.46982688 |
| 23 | * MP0000716_abnormal_immune_system | 2.46045766 |
| 24 | MP0002405_respiratory_system_inflammati | 2.43468912 |
| 25 | * MP0002722_abnormal_immune_system | 2.28244916 |
| 26 | MP0002933_joint_inflammation | 2.11088490 |
| 27 | MP0000689_abnormal_spleen_morphology | 2.07440641 |
| 28 | MP0004947_skin_inflammation | 2.05745265 |
| 29 | MP0010155_abnormal_intestine_physiology | 2.04876218 |
| 30 | MP0003866_abnormal_defecation | 2.02614809 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 1.99019272 |
| 32 | * MP0002429_abnormal_blood_cell | 1.94885337 |
| 33 | MP0002396_abnormal_hematopoietic_system | 1.91244945 |
| 34 | MP0001873_stomach_inflammation | 1.88560400 |
| 35 | MP0002419_abnormal_innate_immunity | 1.85590400 |
| 36 | MP0002132_abnormal_respiratory_system | 1.81963536 |
| 37 | MP0003436_decreased_susceptibility_to | 1.81190028 |
| 38 | MP0004510_myositis | 1.66247996 |
| 39 | MP0000858_altered_metastatic_potential | 1.65097672 |
| 40 | MP0005310_abnormal_salivary_gland | 1.58957778 |
| 41 | MP0001845_abnormal_inflammatory_respons | 1.58510746 |
| 42 | MP0005464_abnormal_platelet_physiology | 1.47813878 |
| 43 | MP0003878_abnormal_ear_physiology | 1.46051278 |
| 44 | MP0005377_hearing/vestibular/ear_phenot | 1.46051278 |
| 45 | MP0005075_abnormal_melanosome_morpholog | 1.29857294 |
| 46 | MP0002009_preneoplasia | 1.29753127 |
| 47 | MP0003448_altered_tumor_morphology | 1.28677997 |
| 48 | MP0003300_gastrointestinal_ulcer | 1.24275994 |
| 49 | MP0001851_eye_inflammation | 1.23092293 |
| 50 | MP0001853_heart_inflammation | 1.23040553 |
| 51 | MP0002163_abnormal_gland_morphology | 1.17314941 |
| 52 | MP0008057_abnormal_DNA_replication | 1.16421837 |
| 53 | MP0003045_fibrosis | 1.10678222 |
| 54 | MP0003786_premature_aging | 1.07384429 |
| 55 | MP0000490_abnormal_crypts_of | 1.04479332 |
| 56 | MP0008469_abnormal_protein_level | 1.04478758 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.03544254 |
| 58 | MP0004808_abnormal_hematopoietic_stem | 0.97501375 |
| 59 | MP0002019_abnormal_tumor_incidence | 0.94927136 |
| 60 | MP0005645_abnormal_hypothalamus_physiol | 0.89970326 |
| 61 | MP0006292_abnormal_olfactory_placode | 0.88561794 |
| 62 | MP0001533_abnormal_skeleton_physiology | 0.88179629 |
| 63 | MP0005166_decreased_susceptibility_to | 0.83877984 |
| 64 | MP0000604_amyloidosis | 0.83399883 |
| 65 | MP0008004_abnormal_stomach_pH | 0.81404671 |
| 66 | MP0001986_abnormal_taste_sensitivity | 0.74131520 |
| 67 | MP0005379_endocrine/exocrine_gland_phen | 0.74123543 |
| 68 | MP0002277_abnormal_respiratory_mucosa | 0.70977673 |
| 69 | MP0000465_gastrointestinal_hemorrhage | 0.69418861 |
| 70 | MP0009764_decreased_sensitivity_to | 0.68500145 |
| 71 | MP0001663_abnormal_digestive_system | 0.68383833 |
| 72 | MP0002095_abnormal_skin_pigmentation | 0.67648225 |
| 73 | MP0000015_abnormal_ear_pigmentation | 0.64567941 |
| 74 | MP0003795_abnormal_bone_structure | 0.64519183 |
| 75 | MP0001765_abnormal_ion_homeostasis | 0.62686308 |
| 76 | MP0002876_abnormal_thyroid_physiology | 0.61515271 |
| 77 | MP0009763_increased_sensitivity_to | 0.61317203 |
| 78 | MP0005174_abnormal_tail_pigmentation | 0.61091194 |
| 79 | MP0005397_hematopoietic_system_phenotyp | 0.59561709 |
| 80 | MP0001545_abnormal_hematopoietic_system | 0.59561709 |
| 81 | MP0010094_abnormal_chromosome_stability | 0.59007621 |
| 82 | MP0003303_peritoneal_inflammation | 0.58769625 |
| 83 | MP0003693_abnormal_embryo_hatching | 0.58377815 |
| 84 | MP0003646_muscle_fatigue | 0.57692080 |
| 85 | MP0003077_abnormal_cell_cycle | 0.57135818 |
| 86 | MP0008873_increased_physiological_sensi | 0.56936796 |
| 87 | MP0008872_abnormal_physiological_respon | 0.55480933 |
| 88 | MP0002693_abnormal_pancreas_physiology | 0.54058248 |
| 89 | MP0001191_abnormal_skin_condition | 0.53884096 |
| 90 | MP0002877_abnormal_melanocyte_morpholog | 0.51728865 |
| 91 | MP0002138_abnormal_hepatobiliary_system | 0.51345476 |
| 92 | MP0009643_abnormal_urine_homeostasis | 0.50854716 |
| 93 | MP0001501_abnormal_sleep_pattern | 0.50788656 |
| 94 | MP0003075_altered_response_to | 0.50664298 |
| 95 | MP0003806_abnormal_nucleotide_metabolis | 0.49521962 |
| 96 | MP0005451_abnormal_body_composition | 0.48530791 |
| 97 | MP0005389_reproductive_system_phenotype | 0.48064007 |
| 98 | MP0000477_abnormal_intestine_morphology | 0.47588303 |
| 99 | MP0003453_abnormal_keratinocyte_physiol | 0.46208674 |
| 100 | MP0005409_darkened_coat_color | 0.45772273 |
| 101 | MP0003879_abnormal_hair_cell | 0.45716552 |
| 102 | MP0001348_abnormal_lacrimal_gland | 0.44906528 |
| 103 | MP0003787_abnormal_imprinting | 0.44714548 |
| 104 | MP0005023_abnormal_wound_healing | 0.44433325 |
| 105 | MP0001905_abnormal_dopamine_level | 0.43133757 |
| 106 | MP0005636_abnormal_mineral_homeostasis | 0.43061000 |
| 107 | MP0001243_abnormal_dermal_layer | 0.42695996 |
| 108 | MP0008995_early_reproductive_senescence | 0.42093066 |
| 109 | MP0002136_abnormal_kidney_physiology | 0.41560450 |
| 110 | MP0001216_abnormal_epidermal_layer | 0.41237339 |
| 111 | MP0008007_abnormal_cellular_replicative | 0.40336743 |
| 112 | MP0009765_abnormal_xenobiotic_induced | 0.40103524 |
| 113 | MP0001881_abnormal_mammary_gland | 0.39826522 |
| 114 | MP0000627_abnormal_mammary_gland | 0.39360673 |
| 115 | MP0001119_abnormal_female_reproductive | 0.39151564 |
| 116 | MP0000920_abnormal_myelination | 0.39003813 |
| 117 | MP0000372_irregular_coat_pigmentation | 0.38771166 |
| 118 | MP0008058_abnormal_DNA_repair | 0.38693275 |
| 119 | MP0003111_abnormal_nucleus_morphology | 0.38562000 |
| 120 | MP0002928_abnormal_bile_duct | 0.38489148 |
| 121 | MP0001919_abnormal_reproductive_system | 0.38130376 |
| 122 | MP0001661_extended_life_span | 0.37962075 |
| 123 | MP0005390_skeleton_phenotype | 0.36644588 |
| 124 | MP0003252_abnormal_bile_duct | 0.35704473 |
| 125 | MP0004145_abnormal_muscle_electrophysio | 0.35352701 |
| 126 | MP0002083_premature_death | 0.34047681 |
| 127 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.33911974 |
| 128 | MP0000249_abnormal_blood_vessel | 0.33756051 |
| 129 | MP0004742_abnormal_vestibular_system | 0.33688772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 7.86130340 |
| 2 | Abnormality of T cell number (HP:0011839) | 7.71158276 |
| 3 | Severe combined immunodeficiency (HP:0004430) | 6.62500742 |
| 4 | Combined immunodeficiency (HP:0005387) | 6.00081645 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.64804797 |
| 6 | Abnormality of T cells (HP:0002843) | 5.32601046 |
| 7 | Autoimmune hemolytic anemia (HP:0001890) | 5.32063123 |
| 8 | IgG deficiency (HP:0004315) | 5.21252455 |
| 9 | Increased IgM level (HP:0003496) | 5.19651997 |
| 10 | Stomatitis (HP:0010280) | 5.09621884 |
| 11 | Aplastic anemia (HP:0001915) | 4.93576527 |
| 12 | Recurrent bronchitis (HP:0002837) | 4.51204634 |
| 13 | Recurrent cutaneous fungal infections (HP:0011370) | 4.50099387 |
| 14 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.50099387 |
| 15 | Thyroiditis (HP:0100646) | 4.49270647 |
| 16 | Chronic otitis media (HP:0000389) | 4.44884011 |
| 17 | Recurrent fungal infections (HP:0002841) | 4.32957224 |
| 18 | Abnormality of eosinophils (HP:0001879) | 4.30281948 |
| 19 | Myositis (HP:0100614) | 4.11848425 |
| 20 | Abnormality of B cell number (HP:0010975) | 4.03323093 |
| 21 | B lymphocytopenia (HP:0010976) | 4.03323093 |
| 22 | Panhypogammaglobulinemia (HP:0003139) | 3.98162182 |
| 23 | Eczematoid dermatitis (HP:0000976) | 3.92440116 |
| 24 | Hypoplasia of the thymus (HP:0000778) | 3.82474462 |
| 25 | Chronic diarrhea (HP:0002028) | 3.82327446 |
| 26 | IgM deficiency (HP:0002850) | 3.76767228 |
| 27 | Eosinophilia (HP:0001880) | 3.74723363 |
| 28 | Leukocytosis (HP:0001974) | 3.68528496 |
| 29 | Cheilitis (HP:0100825) | 3.62168858 |
| 30 | Recurrent viral infections (HP:0004429) | 3.58942146 |
| 31 | Optic neuritis (HP:0100653) | 3.50804067 |
| 32 | Retrobulbar optic neuritis (HP:0100654) | 3.50804067 |
| 33 | Abnormality of macrophages (HP:0004311) | 3.39843221 |
| 34 | Granulocytopenia (HP:0001913) | 3.34231312 |
| 35 | Joint swelling (HP:0001386) | 3.18103644 |
| 36 | Orchitis (HP:0100796) | 3.16859146 |
| 37 | Abnormality of T cell physiology (HP:0011840) | 3.12129959 |
| 38 | Nasal polyposis (HP:0100582) | 3.08945088 |
| 39 | * Lymphopenia (HP:0001888) | 3.06172133 |
| 40 | Pustule (HP:0200039) | 3.01957520 |
| 41 | * Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.00500354 |
| 42 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.99257914 |
| 43 | Parakeratosis (HP:0001036) | 2.97244552 |
| 44 | Hypergammaglobulinemia (HP:0010702) | 2.93652701 |
| 45 | Abnormality of the fingertips (HP:0001211) | 2.92944751 |
| 46 | Meningitis (HP:0001287) | 2.91673113 |
| 47 | Recurrent abscess formation (HP:0002722) | 2.87898868 |
| 48 | Hemoptysis (HP:0002105) | 2.87253402 |
| 49 | Chest pain (HP:0100749) | 2.85953801 |
| 50 | Vasculitis (HP:0002633) | 2.82540930 |
| 51 | Lymphoma (HP:0002665) | 2.73494989 |
| 52 | Recurrent sinusitis (HP:0011108) | 2.72579915 |
| 53 | Obstructive lung disease (HP:0006536) | 2.61948797 |
| 54 | Chronic obstructive pulmonary disease (HP:0006510) | 2.61948797 |
| 55 | Pulmonary infiltrates (HP:0002113) | 2.61075353 |
| 56 | Mediastinal lymphadenopathy (HP:0100721) | 2.58243826 |
| 57 | Encephalitis (HP:0002383) | 2.54831344 |
| 58 | Abnormality of the nasal mucosa (HP:0000433) | 2.51223624 |
| 59 | Recurrent skin infections (HP:0001581) | 2.49731776 |
| 60 | Bronchitis (HP:0012387) | 2.48479874 |
| 61 | Acute hepatic failure (HP:0006554) | 2.48203641 |
| 62 | 3-Methylglutaconic aciduria (HP:0003535) | 2.47563195 |
| 63 | Gastrointestinal infarctions (HP:0005244) | 2.46193122 |
| 64 | Ureteral stenosis (HP:0000071) | 2.40670087 |
| 65 | Hypoproteinemia (HP:0003075) | 2.40386818 |
| 66 | Abnormality of the prostate (HP:0008775) | 2.40247550 |
| 67 | Chronic sinusitis (HP:0011109) | 2.37691054 |
| 68 | Keratoconjunctivitis sicca (HP:0001097) | 2.36301604 |
| 69 | Agammaglobulinemia (HP:0004432) | 2.36174795 |
| 70 | Hemiplegia (HP:0002301) | 2.31663169 |
| 71 | Keratitis (HP:0000491) | 2.30376534 |
| 72 | IgA deficiency (HP:0002720) | 2.29862793 |
| 73 | Ureteral obstruction (HP:0006000) | 2.25881994 |
| 74 | Abnormal albumin level (HP:0012116) | 2.21891088 |
| 75 | Hypoalbuminemia (HP:0003073) | 2.21891088 |
| 76 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.19725965 |
| 77 | Autoimmune thrombocytopenia (HP:0001973) | 2.18787626 |
| 78 | Unilateral renal agenesis (HP:0000122) | 2.18614335 |
| 79 | Pancytopenia (HP:0001876) | 2.17438337 |
| 80 | Increased intramyocellular lipid droplets (HP:0012240) | 2.17289434 |
| 81 | Abnormality of DNA repair (HP:0003254) | 2.17266159 |
| 82 | Keratoconjunctivitis (HP:0001096) | 2.14057302 |
| 83 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.05984562 |
| 84 | Oral leukoplakia (HP:0002745) | 2.00981765 |
| 85 | Pulmonary fibrosis (HP:0002206) | 1.99574574 |
| 86 | Gangrene (HP:0100758) | 1.97746969 |
| 87 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.97322613 |
| 88 | Skin rash (HP:0000988) | 1.96472457 |
| 89 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.96323969 |
| 90 | Premature graying of hair (HP:0002216) | 1.94214663 |
| 91 | Mitochondrial inheritance (HP:0001427) | 1.93724678 |
| 92 | Polyneuropathy (HP:0001271) | 1.90303835 |
| 93 | Abnormality of male internal genitalia (HP:0000022) | 1.90097286 |
| 94 | Bronchiectasis (HP:0002110) | 1.88936749 |
| 95 | Gingivitis (HP:0000230) | 1.88781447 |
| 96 | Microcytic anemia (HP:0001935) | 1.88635979 |
| 97 | Muscle fiber atrophy (HP:0100295) | 1.88402563 |
| 98 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.88287487 |
| 99 | Abnormality of the endocardium (HP:0004306) | 1.87332324 |
| 100 | Arterial thrombosis (HP:0004420) | 1.86411351 |
| 101 | Glomerulopathy (HP:0100820) | 1.84570400 |
| 102 | Abnormality of the pleura (HP:0002103) | 1.82678931 |
| 103 | Increased IgE level (HP:0003212) | 1.82542239 |
| 104 | Poikiloderma (HP:0001029) | 1.82315028 |
| 105 | Spontaneous hematomas (HP:0007420) | 1.82161205 |
| 106 | Anorexia (HP:0002039) | 1.80463324 |
| 107 | Increased muscle lipid content (HP:0009058) | 1.79878048 |
| 108 | Type 2 muscle fiber atrophy (HP:0003554) | 1.77012109 |
| 109 | Epistaxis (HP:0000421) | 1.76728963 |
| 110 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.75582195 |
| 111 | Basal cell carcinoma (HP:0002671) | 1.75184223 |
| 112 | Pulmonary embolism (HP:0002204) | 1.75182830 |
| 113 | Congenital stationary night blindness (HP:0007642) | 1.74927521 |
| 114 | Clubbing of toes (HP:0100760) | 1.72993679 |
| 115 | Renal cortical cysts (HP:0000803) | 1.72990037 |
| 116 | Recurrent bacterial skin infections (HP:0005406) | 1.72977337 |
| 117 | Acute necrotizing encephalopathy (HP:0006965) | 1.72895252 |
| 118 | Inflammation of the large intestine (HP:0002037) | 1.71864234 |
| 119 | Basal ganglia calcification (HP:0002135) | 1.71515799 |
| 120 | Gastrointestinal inflammation (HP:0004386) | 1.70981565 |
| 121 | Ectropion (HP:0000656) | 1.70587414 |
| 122 | Increased hepatocellular lipid droplets (HP:0006565) | 1.69247828 |
| 123 | Severe visual impairment (HP:0001141) | 1.68830596 |
| 124 | Large eyes (HP:0001090) | 1.68657607 |
| 125 | Alopecia of scalp (HP:0002293) | 1.68387452 |
| 126 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.67344173 |
| 127 | Hypochromic anemia (HP:0001931) | 1.66501154 |
| 128 | Entropion (HP:0000621) | 1.66344962 |
| 129 | Abnormality of the pericardium (HP:0001697) | 1.64826808 |
| 130 | Petechiae (HP:0000967) | 1.63483152 |
| 131 | Prolonged bleeding time (HP:0003010) | 1.62703062 |
| 132 | Skin ulcer (HP:0200042) | 1.61879391 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.86551480 |
| 2 | MAP4K1 | 5.00870105 |
| 3 | ZAP70 | 3.55233048 |
| 4 | IKBKE | 3.40801275 |
| 5 | ITK | 3.22093977 |
| 6 | FGFR4 | 2.99891689 |
| 7 | SIK3 | 2.81835650 |
| 8 | JAK3 | 2.76933613 |
| 9 | KDR | 2.55528742 |
| 10 | TYK2 | 2.49548141 |
| 11 | NLK | 2.21594673 |
| 12 | TAOK3 | 2.09663670 |
| 13 | TEC | 2.08294537 |
| 14 | LCK | 2.06193222 |
| 15 | MAP3K14 | 2.04107368 |
| 16 | TBK1 | 1.98490891 |
| 17 | TESK2 | 1.96272262 |
| 18 | JAK1 | 1.94172628 |
| 19 | FGFR3 | 1.86798351 |
| 20 | NME2 | 1.85978622 |
| 21 | SIK2 | 1.78847796 |
| 22 | STK10 | 1.71955285 |
| 23 | RIPK4 | 1.69559434 |
| 24 | MAP3K12 | 1.66723798 |
| 25 | GRK6 | 1.66713213 |
| 26 | CSK | 1.61771904 |
| 27 | SYK | 1.59368775 |
| 28 | BLK | 1.50121431 |
| 29 | MST4 | 1.48922524 |
| 30 | HCK | 1.47867619 |
| 31 | BCKDK | 1.46438439 |
| 32 | BTK | 1.43446571 |
| 33 | SCYL2 | 1.39134668 |
| 34 | IRAK4 | 1.36755199 |
| 35 | CAMKK2 | 1.30283169 |
| 36 | MARK3 | 1.24893456 |
| 37 | KIT | 1.18447247 |
| 38 | TYRO3 | 1.18032134 |
| 39 | SIK1 | 1.15177917 |
| 40 | TNK2 | 1.13382499 |
| 41 | PASK | 1.11897556 |
| 42 | ZAK | 1.09790930 |
| 43 | TLK1 | 1.07979927 |
| 44 | CLK1 | 1.02859242 |
| 45 | PRKCQ | 1.02806199 |
| 46 | PRKCH | 1.00584603 |
| 47 | LYN | 0.95497634 |
| 48 | CAMKK1 | 0.94338380 |
| 49 | BUB1 | 0.92379541 |
| 50 | IKBKB | 0.92164171 |
| 51 | VRK2 | 0.85128951 |
| 52 | MAPKAPK3 | 0.77953743 |
| 53 | ADRBK2 | 0.75568309 |
| 54 | PIK3CG | 0.73388891 |
| 55 | STK16 | 0.72996480 |
| 56 | MAPK11 | 0.71724997 |
| 57 | PIK3CA | 0.71317239 |
| 58 | MAP3K13 | 0.71100373 |
| 59 | CDK3 | 0.64266361 |
| 60 | FYN | 0.61059525 |
| 61 | SRPK1 | 0.60216257 |
| 62 | MARK2 | 0.59264009 |
| 63 | RPS6KA4 | 0.57816726 |
| 64 | PIM1 | 0.55813583 |
| 65 | EIF2AK1 | 0.53789431 |
| 66 | DAPK1 | 0.53600536 |
| 67 | JAK2 | 0.53465675 |
| 68 | MAP2K6 | 0.53443159 |
| 69 | TAOK2 | 0.52158351 |
| 70 | PRKD2 | 0.51984701 |
| 71 | WNK4 | 0.50414613 |
| 72 | FES | 0.49887110 |
| 73 | CHUK | 0.48179384 |
| 74 | PDGFRB | 0.46973895 |
| 75 | BMPR2 | 0.46344327 |
| 76 | TESK1 | 0.45246486 |
| 77 | EEF2K | 0.44504533 |
| 78 | IGF1R | 0.44245642 |
| 79 | BRD4 | 0.41593531 |
| 80 | PRPF4B | 0.41454929 |
| 81 | STK4 | 0.40682509 |
| 82 | MAPKAPK2 | 0.40668459 |
| 83 | GRK1 | 0.40464472 |
| 84 | MAP3K7 | 0.39621701 |
| 85 | * INSR | 0.38323252 |
| 86 | FGFR2 | 0.36989819 |
| 87 | LIMK1 | 0.36842516 |
| 88 | TGFBR2 | 0.35608893 |
| 89 | CDK12 | 0.35405856 |
| 90 | STK38 | 0.34865606 |
| 91 | MAP3K3 | 0.34643680 |
| 92 | IRAK2 | 0.33336460 |
| 93 | IRAK1 | 0.32508450 |
| 94 | LRRK2 | 0.31893487 |
| 95 | CDK4 | 0.31823547 |
| 96 | MYLK | 0.30965495 |
| 97 | TNIK | 0.30156564 |
| 98 | MAP3K10 | 0.30034361 |
| 99 | MATK | 0.30027363 |
| 100 | ACVR1B | 0.29891628 |
| 101 | FGFR1 | 0.28867824 |
| 102 | MUSK | 0.28792883 |
| 103 | HIPK2 | 0.28412446 |
| 104 | NUAK1 | 0.27930832 |
| 105 | EIF2AK2 | 0.26100693 |
| 106 | MAPK7 | 0.25184384 |
| 107 | MAP4K2 | 0.24231495 |
| 108 | ATR | 0.23683248 |
| 109 | EIF2AK3 | 0.23669044 |
| 110 | RPS6KA5 | 0.23305122 |
| 111 | CSF1R | 0.22149172 |
| 112 | PRKCD | 0.21605044 |
| 113 | MAPK3 | 0.20627350 |
| 114 | EPHA3 | 0.20197589 |
| 115 | MAP3K5 | 0.20131413 |
| 116 | MAP3K1 | 0.19990327 |
| 117 | PRKCA | 0.19870232 |
| 118 | VRK1 | 0.18087415 |
| 119 | CDK9 | 0.17878889 |
| 120 | GRK5 | 0.17674433 |
| 121 | GRK7 | 0.17639688 |
| 122 | STK24 | 0.16924383 |
| 123 | MAP3K11 | 0.16009501 |
| 124 | TRIM28 | 0.15869791 |
| 125 | ABL1 | 0.15476136 |
| 126 | SRC | 0.15165295 |
| 127 | PRKCB | 0.15003742 |
| 128 | MAPK12 | 0.14849816 |
| 129 | TAOK1 | 0.14427447 |
| 130 | MELK | 0.14274980 |
| 131 | PDK1 | 0.13315206 |
| 132 | EGFR | 0.13271916 |
| 133 | CDK8 | 0.12748542 |
| 134 | PAK1 | 0.12105700 |
| 135 | NEK6 | 0.12050942 |
| 136 | CSNK1D | 0.11759448 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Primary immunodeficiency_Homo sapiens_hsa05340 | 5.91101261 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.11560173 |
| 3 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.69573866 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.51280303 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.06826430 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.92212669 |
| 7 | * Measles_Homo sapiens_hsa05162 | 2.91174260 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.72827440 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.72692163 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.70199602 |
| 11 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.48964039 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.22127855 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.12895374 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.83029906 |
| 15 | Viral myocarditis_Homo sapiens_hsa05416 | 1.76189775 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.72326331 |
| 17 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.60635013 |
| 18 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.59859369 |
| 19 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.59839236 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.56127371 |
| 21 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.45017342 |
| 22 | Ribosome_Homo sapiens_hsa03010 | 1.29593096 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.29325877 |
| 24 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.28804215 |
| 25 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.23003166 |
| 26 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.19825188 |
| 27 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.18037599 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.17867290 |
| 29 | Asthma_Homo sapiens_hsa05310 | 1.14908698 |
| 30 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.13620447 |
| 31 | Hepatitis B_Homo sapiens_hsa05161 | 1.12742418 |
| 32 | Parkinsons disease_Homo sapiens_hsa05012 | 1.08313955 |
| 33 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.06052948 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.03614643 |
| 35 | * HTLV-I infection_Homo sapiens_hsa05166 | 1.02252434 |
| 36 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.02034996 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.00996985 |
| 38 | Spliceosome_Homo sapiens_hsa03040 | 1.00747097 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 0.99221610 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.97077406 |
| 41 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.93960072 |
| 42 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.88768197 |
| 43 | Malaria_Homo sapiens_hsa05144 | 0.88433621 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.87401618 |
| 45 | Apoptosis_Homo sapiens_hsa04210 | 0.83380406 |
| 46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.76837178 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.75968930 |
| 48 | DNA replication_Homo sapiens_hsa03030 | 0.75067524 |
| 49 | Proteasome_Homo sapiens_hsa03050 | 0.74180460 |
| 50 | Tuberculosis_Homo sapiens_hsa05152 | 0.72613840 |
| 51 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.71856149 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.71670181 |
| 53 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.69927816 |
| 54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.69018673 |
| 55 | Hepatitis C_Homo sapiens_hsa05160 | 0.67089153 |
| 56 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.66986652 |
| 57 | Alzheimers disease_Homo sapiens_hsa05010 | 0.65686507 |
| 58 | Basal transcription factors_Homo sapiens_hsa03022 | 0.64766405 |
| 59 | Colorectal cancer_Homo sapiens_hsa05210 | 0.63645818 |
| 60 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.62427760 |
| 61 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.62079356 |
| 62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61625836 |
| 63 | Salmonella infection_Homo sapiens_hsa05132 | 0.61461690 |
| 64 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.61219089 |
| 65 | Legionellosis_Homo sapiens_hsa05134 | 0.61070684 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.60217386 |
| 67 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.59706670 |
| 68 | Homologous recombination_Homo sapiens_hsa03440 | 0.58215105 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57880828 |
| 70 | RNA degradation_Homo sapiens_hsa03018 | 0.55269011 |
| 71 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.54410662 |
| 72 | Pertussis_Homo sapiens_hsa05133 | 0.51272626 |
| 73 | Other glycan degradation_Homo sapiens_hsa00511 | 0.51181959 |
| 74 | Platelet activation_Homo sapiens_hsa04611 | 0.50975167 |
| 75 | Mismatch repair_Homo sapiens_hsa03430 | 0.48276938 |
| 76 | Phototransduction_Homo sapiens_hsa04744 | 0.48134627 |
| 77 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45587101 |
| 78 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45030548 |
| 79 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44046862 |
| 80 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43652903 |
| 81 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.43182899 |
| 82 | Base excision repair_Homo sapiens_hsa03410 | 0.42189814 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.42021791 |
| 84 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.40170841 |
| 85 | Adherens junction_Homo sapiens_hsa04520 | 0.39463860 |
| 86 | Huntingtons disease_Homo sapiens_hsa05016 | 0.39044255 |
| 87 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.38773402 |
| 88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.38017525 |
| 89 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.37557425 |
| 90 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.34775863 |
| 91 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34633238 |
| 92 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33679578 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.32998182 |
| 94 | RNA polymerase_Homo sapiens_hsa03020 | 0.32883081 |
| 95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32165338 |
| 96 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.31918103 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31874832 |
| 98 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.30464738 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.29465267 |
| 100 | Endocytosis_Homo sapiens_hsa04144 | 0.29010963 |
| 101 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.28670279 |
| 102 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.27979306 |
| 103 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.27316836 |
| 104 | Cell cycle_Homo sapiens_hsa04110 | 0.25489899 |
| 105 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.24917893 |
| 106 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24782317 |
| 107 | Thyroid cancer_Homo sapiens_hsa05216 | 0.24139819 |
| 108 | Protein export_Homo sapiens_hsa03060 | 0.23183465 |
| 109 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.23154401 |
| 110 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.21805619 |
| 111 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.21400644 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.18267341 |
| 113 | Olfactory transduction_Homo sapiens_hsa04740 | 0.18096904 |
| 114 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.16341498 |
| 115 | Pathways in cancer_Homo sapiens_hsa05200 | 0.15996862 |
| 116 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.14980957 |
| 117 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.14863992 |
| 118 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.14526767 |
| 119 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.13936948 |
| 120 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.13893089 |
| 121 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.13137232 |
| 122 | Peroxisome_Homo sapiens_hsa04146 | 0.11595250 |
| 123 | Purine metabolism_Homo sapiens_hsa00230 | 0.10171160 |
| 124 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.09938408 |
| 125 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.06542397 |
| 126 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.05978193 |
| 127 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.05396543 |
| 128 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.04642566 |
| 129 | Phagosome_Homo sapiens_hsa04145 | 0.02070197 |

